Valeant CEO Addresses Investor Concerns In Letter; Will It Help The Stock Price?

After watching the stock’s share price fall by more than 17 percent in five days, Valeant Pharmaceuticals International Inc VRX 5.06% CEO J. Michael Pearson decided to take matters into his own hands on Monday by sending a letter to his employees assuring them that the company’s business model and fundamentals are sound. Democratic presidential frontrunner Hillary Clinton’s plan to rein in prescription drug prices has slammed the biotech sector hard in recent days, but Pearson assured his employees (and shareholders) that the company is in a strong position to continue to grow regardless of potential new drug price regulation.

Price Increases

According to Pearson, fears that new legislation could threaten Valeant’s ability to raise prices on its drugs and eliminate the company’s growth are…

Click here to continue reading

My book is on sale for just $0.99 through the end of September only!

Then it goes back to its regular price of $79.99, so you’d better get it now….

Want to learn more about how to profit off the stock market? Or maybe you just want to be able to look sophisticated in front of your coworkers when they ask you what you are reading on your Kindle, and you’d prefer to tell them “Oh, I’m just reading a book about stock market analysis,” rather than the usual “Oh, I’m just looking at pics of my ex-girlfriend on Facebook.” For these reasons and more, check out my book, Beating Wall Street with Common SenseI don’t have a degree in finance; I have a degree in neuroscience. You don’t have to predict what stocks will do if you can predict what traders will do and be one step ahead of them. I made a 400% return in the stock market over five years using only basic principles of psychology and common sense. Beating Wall Street with Common Sense is now available on Amazon, and is always available on your local internet!